Amikacin sulfateMeSH concept

https://www.ema.europa.eu/en/medicines/human/EPAR/arikayce-liposomal
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
amikacin
amikacin
orphan drug production
amikacin sulfate
amikacin sulfate
amikacin
anti-bacterial agents
anti-bacterial agents
adult
mycobacterium avium complex
mycobacterium avium-intracellulare infection
Pulmonary Mycobacterium avium complex infection (disorder)
pneumonia
administration, inhalation
drug therapy, combination
nebulizers
Amikacin liposome (substance)
Amikacin liposome (substance)
pregnancy
bottle feeding
protein synthesis inhibitors
protein synthesis inhibitors
drug evaluation, preclinical
Mycobacterium Avium pulmonary infection
nebulizers and vaporizers

---
http://www.has-sante.fr/portail/jcms/c_2608683/fr/amikacine-mylan
2016
false
false
false
France
French
amikacin
evaluation of the transparency committee
amikacin
amikacin sulfate
anti-bacterial agents
injections
Gram-Negative bacterial infections
drug therapy, combination
treatment outcome
insurance, health, reimbursement
malignant staphylococcal infection of the face
staphylococcal skin infections
sepsis
endocarditis, bacterial
bacterial urogenital infection
male urogenital diseases
female urogenital diseases
urinary tract infections
meningitis, bacterial
arthritis, infectious
antibiotic therapy

---